Health-related quality of life after kidney transplantation in comparison intermittent hemodialysis, peritoneal dialysis, and normal controls

Health-related quality of life after kidney transplantation in comparison intermittent hemodialysis, peritoneal dialysis, and normal controls
复制标题

DOI:
10.1016/j.transproceed.2006.01.016
复制
发表时间:
2006-03-01
影响因子:
0.9
通讯作者:
Emel, A
Emel, A
中科院分区:
医学4区
文献类型:
--
作者:
Ogutmen, B;Yildirim, A;Emel, A

文献摘要

被引文献

相似文献

本研究的目的是比较肾移植患者的生活质量(QOL)。 QOL是衡量医疗效果的重要指标之一。在这项横断面研究中,对 302 名肾移植受者的生活质量进行了分析,并与 64 名血液透析 (HD) 患者、207 名腹膜透析 (PD) 患者和 278 名正常对照 (NC) 进行了比较,这些患者在年龄、性别、教育和职业方面与移植患者尽可能匹配。所有小组都被要求通过对社会人口统计数据、诺丁汉健康概况 (NHP) 和简式 36 (SF-36) 的土耳其改编工具进行回应来估计他们的主观生活质量。移植受者明显比 HD 和 PD 患者年轻 (P < .0001.)。正常对照和移植患者年龄之间没有统计学上的显着差异。在三种肾脏替代方法中,移植患者的生活质量明显优于 HD 或 PD 患者 (P < .0001)。通过 NHP 和 SF-36 量表测量的 QOL 显示,正常人群在统计学上显着优于移植受者 (P < .0001)。与其他替代方法相比,移植肾替代疗法可提供更好的生活质量。
The purpose of this study was to compare the quality of life (QOL) in renal transplantation patients. QOL is one of the important indicators of the effects of medical treatment. In this cross-sectional study, QOL was analyzed in 302 renal transplant recipients compared with 64 hemodialysis (HD) patients, 207 (PD) peritoneal dialysis patients, and 278 normal controls (NC) matched as closely as possible to the grafted patients regarding age, gender, education, and occupation. All groups were asked to estimate their subjective QOL by responding to sociodemographic data, Turkish adapted instruments of the Nottingham Health profile (NHP), and the Short-form 36 (SF-36). Transplant recipients were significantly younger than the HD and PD patients (P < .0001.). There was no statistically significant differences between normal controls and transplant patients ages. Among the three renal replacement methods, QOL in transplants was clearly better than that in HD or PD patients (P < .0001). The QOL measured by the NHP and SF-36 scale showed that the normal population was statistically significantly better than the transplant recipients (P < .0001). Transplant renal replacement therapy provides a better QOL compared with other replacement methods.